3-n-methylspiperone has been researched along with piperidines in 2 studies
Studies (3-n-methylspiperone) | Trials (3-n-methylspiperone) | Recent Studies (post-2010) (3-n-methylspiperone) | Studies (piperidines) | Trials (piperidines) | Recent Studies (post-2010) (piperidines) |
---|---|---|---|---|---|
155 | 6 | 7 | 40,235 | 5,221 | 14,545 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, D; Ehrenkaufer, RL; Evora, PH; Greenberg, JH; Luedtke, RR; Mach, RH; Morton, TE; Nowak, PA; Reivich, M; Shao, L | 1 |
Dannals, RF; GrĂ¼nder, G; Howard, DR; Offord, SJ; Ravert, HT; Salzmann, JK; Szymanski, S; Wilson, PD; Wong, DF; Yokoi, F | 1 |
2 other study(ies) available for 3-n-methylspiperone and piperidines
Article | Year |
---|---|
PET imaging studies of dopamine D2 receptors: comparison of [18F]N-methylspiperone and the benzamide analogues [18F]MABN and [18F]MBP in baboon brain.
Topics: Animals; Benzamides; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Female; Fluorine Radioisotopes; Papio; Piperidines; Receptors, Dopamine D2; Spiperone; Tissue Distribution; Tomography, Emission-Computed | 1995 |
Time course of 5-HT2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography.
Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Female; Fluorobenzenes; Humans; Male; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Spiperone; Time Factors; Tomography, Emission-Computed | 1997 |